SEI Investments’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-26,128	Closed	-$4.78M	–	2691
2021 Q2	$4.78M	Sell	26,128 -12,925	-33%	-$2.22M	0.01%	1104
2021 Q1	$6.08M	Sell	39,053 -40,095	-51%	-$6.2M	0.02%	927
2020 Q4	$12.4M	Sell	79,148 -31,220	-28%	-$4.01M	0.03%	543
2020 Q3	$12.5M	Sell	110,368 -17,157	-13%	-$1.85M	0.04%	459
2020 Q2	$14.4M	Sell	127,525 -12,150	-9%	-$1.29M	0.04%	399
2020 Q1	$12.6M	Sell	139,675 -421,463	-75%	-$41.4M	0.05%	385
2019 Q4	$60.7M	Sell	561,138 -220,884	-28%	-$23.6M	0.18%	96
2019 Q3	$76.6M	Sell	782,022 -11,865	-1%	-$1.34M	0.2%	82
2019 Q2	$104M	Buy	793,887 +127,884	+19%	+$16.5M	0.34%	45
2019 Q1	$90M	Buy	666,003 +457,031	+219%	+$56.8M	0.3%	50
2018 Q4	$28.9M	Buy	208,972 +3,558	+2%	+$421K	0.1%	198
2018 Q3	$28.6M	Buy	205,414 +63,793	+45%	+$8M	0.1%	185
2018 Q2	$17.6M	Buy	141,621 +115,031	+433%	+$13.4M	0.06%	340
2018 Q1	$2.96M	Sell	26,590 -41,682	-61%	-$4.98M	0.01%	1057
2017 Q4	$7.92M	Sell	68,272 -26,719	-28%	-$3.25M	0.03%	697
2017 Q3	$13.3M	Sell	94,991 -13,351	-12%	-$1.81M	0.05%	472
2017 Q2	$13.2M	Sell	108,342 -156,852	-59%	-$18.3M	0.05%	438
2017 Q1	$32.2M	Sell	265,194 -77,511	-23%	-$9.99M	0.14%	157
2016 Q4	$41.9M	Buy	342,705 +74,948	+28%	+$9.17M	0.2%	110
2016 Q3	$32.8M	Buy	267,757 +60,810	+29%	+$7.83M	0.17%	138
2016 Q2	$24.2M	Sell	206,947 -119,570	-37%	-$17M	0.14%	172
2016 Q1	$45.5M	Buy	326,517 +9,042	+3%	+$1.33M	0.28%	80
2015 Q4	$60.6M	Buy	317,475 +104,022	+49%	+$18.2M	0.37%	42
2015 Q3	$33.4M	Sell	213,453 -1,168	-0.5%	-$213K	0.31%	73
2015 Q2	$38.8M	Buy	214,621 +39,509	+23%	+$6.82M	0.35%	64
2015 Q1	$30.3M	Sell	175,112 -22,999	-12%	-$4.16M	0.26%	89
2014 Q4	$36.6M	Buy	+198,111	New	+$36.7M	0.32%	70

Other funds holding ALXN